Zimmer Biomet Holdings, Inc. (ZBH) |
|
129.2 2.44 (1.92%)
|
03-31 16:03 |
|
Open: |
127.92 |
Pre. Close: |
126.76 |
|
High:
|
129.32 |
Low:
|
127.7 |
|
Volume:
|
1,212,585 |
Market Cap:
|
27,140(M) |
|
|
|
Technical analysis |
as of: 2023-03-31 4:23:24 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 151.04  One year: 176.42 |
| Support: |
Support1: 124.16 Support2: 120.98 |
| Resistance: |
Resistance1: 129.32 Resistance2: 151.04 |
| Pivot: |
126.07 |
| Moving Average: |
MA(5): 126.95 MA(20): 125.33
MA(100): 123.64 MA(250): 117.16 |
| MACD: |
MACD(12,26): 0.6 Signal(9): 0.2 |
| Stochastic oscillator: |
%K(14,3): 82.6 %D(3): 74.5 |
| RSI: |
RSI(14): 62.3 |
| 52-week: |
High: 135.05 Low: 100.38 |
| Average Vol(K): |
3-Month: 1,424 (K) 10-Days: 851 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ ZBH ] has closed It is unclear right now based on current values. 44.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
129.33 - 129.78 |
129.78 - 130.2 |
|
Low:
|
126.38 - 126.97 |
126.97 - 127.51 |
|
Close:
|
128.19 - 129.01 |
129.01 - 129.76 |
|
Company Description |
|
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana. |
Headline News |
Fri, 31 Mar 2023
Zimmer Biomet Holdings Inc. stock rises Friday, outperforms market - MarketWatch
Fri, 31 Mar 2023
Hartford Investment Management Co. Sells 4789 Shares of Zimmer ... - MarketBeat
Thu, 30 Mar 2023
Fitch Affirms Zimmer Biomet at 'BBB'; Outlook Stable - Fitch Ratings
Wed, 29 Mar 2023
Zimmer Biomet's ROSA HIP with ONE Planner Hip Awarded ... - PR Newswire
Thu, 23 Mar 2023
Guru Fundamental Report for ZBH - Nasdaq
Wed, 22 Mar 2023
Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
210 (M) |
| Shares Float |
209 (M) |
|
% Held by Insiders
|
0 (%) |
|
% Held by Institutions
|
90.9 (%) |
|
Shares Short
|
3,160 (K) |
|
Shares Short P.Month
|
2,380 (K) |
Stock Financials |
|
EPS
|
1.37 |
|
EPS Est Next Qtl
|
2.26 |
|
EPS Est This Year
|
8.22 |
|
EPS Est Next Year
|
8.76 |
|
Book Value (p.s.)
|
57.5 |
|
Profit Margin (%)
|
3.3 |
|
Operating Margin (%)
|
19 |
|
Return on Assets (ttm)
|
3.7 |
|
Return on Equity (ttm)
|
2.3 |
|
Qtrly Rev. Growth
|
2.7 |
|
Gross Profit (p.s.)
|
23.42 |
|
Sales Per Share
|
33.03 |
|
EBITDA (p.s.)
|
10.71 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
1,280 (M) |
|
Levered Free Cash Flow
|
1,700 (M) |
Stock Valuations |
|
PE Ratio
|
94.24 |
|
PEG Ratio
|
3 |
|
Price to Book value
|
2.24 |
|
Price to Sales
|
3.9 |
|
Price to Cash Flow
|
21.18 |
Stock Dividends |
|
Dividend
|
0.23 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0.1% |
|
Dividend Pay Date
|
2022-01-30 |
|
Ex-Dividend Date
|
2021-12-26 |
|
Your Ad Here
|
|
